This Obesity-Focused ETF Is Seeing Hefty Gains

pexels-photo-552056It has become a global epidemic, and the number of people affected by it is only expected to increase exponentially going forward: obesity. It should not come as a surprise then that an exchange-traded fund that tracks companies that are focused on the treatment of – and mitigating the growth of – obesity has seen strong gains in the last year. For more on this ETF, its performance – and how it is well positioned regardless of where the fight against obesity goes from here – CLICK HERE.

Read More

3 Cheap Stocks Poised For A Breakout

2017-12-11 08_44_01-Free stock photo of abstract, arrows, blurBreaking out is hard to do – but the three stocks highlighted in today’s article may be positioned to do just that. Specifically, the author highlights three stocks that are cheap based on their price-to-earnings ratio, trading just below their 52-week highs, and poised for breakouts. For these three stocks – a global leader in mobile communications, a big player in everything glass (including, probably, the screen you are reading this on), and a multinational financial services company – CLICK HERE.

Read More

Cheap, Profitable & Growing: 5 Stocks Under $5 That Could Be Big Winners

2017-12-11 08_37_49-Free stock photo of bank, banknotes, billToday’s article highlights several cheap stocks that could be big winners – with the author noting that cheap stocks “are the ones that have been proven to be most likely to deliver large gains.” (In fact, the author cites one study which found that, in a typical quarter, cheap stocks delivered more than six times the average return of their more expensive counterparts). The author screened for cheap stocks (trading under $5) that are profitable and growing. For the five stocks that passed this screen, CLICK HERE.

Read More

Which Of These “Century Club” Dividend Payers Are Still Good Buys Today?

2017-12-03 16_41_46-Free stock photo of 17th Century, bay, beachThe five stocks featured in today’s article have been paying out dividends for at least 100 years – through wars, depressions, recessions, market crashes and more. Given this impressive feat, the author of today’s article acknowledges that “it’s a good bet that any company on this list has a safe dividend that will withstand the test of time.” However, he points out that this doesn’t necessarily mean that these companies are good investments anymore. Which of these five members of the “Century Club” may be past their prime – and which appear to still be good income investments today? CLICK HERE.

Read More

Where Will The Real Opportunities Be In The Electric Vehicle Revolution?

2017-12-03 16_38_07-Free stock photo of alternative, auto, automobileOf the electric vehicle revolution, the author of today’s article is adamant that “the implications for investors is too compelling to ignore.” Indeed, global sales of electric vehicles are soaring – and many analysts are forecasting that, by 2040, EV sales could exceed 60 million per year. Those looking to profit from the massive growth that lies ahead may be wise to look beyond the likes of Tesla, however. The author outlines how China – as well as copper and other metals – will be where the real action is. CLICK HERE.

Read More

MGGA! Do Bitcoin’s Risks Help Make Gold Great Again?

2017-12-03 16_36_57-Free stock photo of chart, data, deskBitcoin recently passed the $10,000 mark, reflecting a surge of more than 850% since the beginning of this year. And as bitcoin achieved this milestone, Google searches for “Bitcoin Bubble” peaked. The author of today’s article notes that “Bitcoin has many factions concerned” and outlines the primary risks associated with the asset – as well as why those risks make gold attractive. For his argument as to why one should “buy gold and bitcoin, but only expect the grown-up to protect you”, CLICK HERE.

Read More

When Traditional Assets Meet Crypto-Trading

2017-11-27 06_30_23-Free stock photo of buildings, businessman, cityWhile the trading of cryptocurrency assets is garnering a great deal of interest, today’s article notes that some investors are looking to be able to trade traditional assets – such as stocks, bonds, options and gold – in the same manner – and the author proceeds to highlight “three new operators [that] are among those developing trading platforms to meet this need, with blockchain-based tokens pegged to the underlying assets.” To read more about these three up-and-coming trading platforms, CLICK HERE.

Read More

Crude Forecasts: Where Will Oil Be In November 2018?

2017-11-27 06_27_54-Free stock photo of business, chimneys, dirtyAt the recent Abu Dhabi Petroleum Exhibition & Conference a number of senior oil executives agreed that, come this time next year, the price of crude oil will essentially be where it is today – around $60 a barrel. The author of today’s article, however, disagrees with that forecast, predicting that oil will have risen to $80 a barrel by November 2018. Why does he believe that the decline in volatility seen in other assets will not necessarily apply to oil? CLICK HERE.

Read More

“Too Cheap To Ignore”: 3 Stocks That Could Be Great Value Investments In This Pricey Market

2017-11-26 21_02_35-Free stock photo of batch, books, documentNo matter how pricey the market may be (and most would agree the market is pretty pricey right now), there is always some value to be found. Today’s article highlights three stocks that are currently trading at incredibly cheap valuations – and which the authors believe could be great value investments. To find out what these three stocks are – an automaker stock, a firearms and outdoor sports stock, and an oil and gas equipment and components provider – CLICK HERE.

Read More

6 Biotech Stocks To Ride The Sector’s Return To Strength

2017-11-21 19_37_59-Free stock photo of clock, hours, minutesThe biotech sector has been weak of late – and as a result now may be the time to get in. Today’s article looks at some of the factors that lie behind the sector’s current performance – including the delay in getting tax reform passed and the “biotech buyout frenzy” that, despite expectations, failed to come to pass this year – and highlights six biotech stocks that may be good candidates for riding a biotech rebound. For more, CLICK HERE.

Read More